Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA) 3 December 2018
Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) 14 November 2018
Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role 6 November 2018
Farma Industria Ticino and Ticino’s pharmaceutical companies in Madrid for CPhI Worldwide 2018 31 October 2018
Cigalah Medpharm announces the launch in Saudi Arabia and United Arab Emirates of Nexodyn® AOS, the Tehclo-based wound cleanser developed by the Swiss Pharma Company APR 18 October 2018
Linkedin